Kronos Worldwide, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US50105F1057
USD
4.78
-0.1 (-2.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Kronos Worldwide, Inc. stock-summary
stock-summary
Kronos Worldwide, Inc.
Specialty Chemicals
Kronos Worldwide, Inc. (Kronos) is a producer and marketer of titanium dioxide (TiO2) pigments, a base industrial product that is used in a range of applications. The Company, along with its distributors and agents, sells and provides technical services for its products with sales in Europe and North America. It offers its customers a portfolio of products that include TiO2 pigment grades under the Kronos brand, which provides a range of performance properties. It offers its products to domestic and international paint, plastics, decorative laminate and paper manufacturers. It ships TiO2 to its customers in either a powder or slurry form through rail, truck or ocean carrier. It sells and provides technical services for its products in three end use markets, which include coatings, plastics and paper. It produces TiO2 in two crystalline forms, which include rutile and anatase. Rutile TiO2 is manufactured using both a chloride production process and a sulfate production process.
Company Coordinates stock-summary
Company Details
5430 Lyndon B Johnson Fwy Ste 1700 , DALLAS TX : 75240-2620
stock-summary
Tel: 1 972 2331700
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 43 Schemes (9.09%)

Foreign Institutions

Held by 64 Foreign Institutions (1.61%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Loretta Feehan
Non-Executive Chairman of the Board
Mr. Robert Graham
Vice Chairman of the Board, President and Chief Executive Officer
Mr. John Harper
Independent Director
Ms. Meredith Mendes
Independent Director
Mr. Cecil Moore
Independent Director
Gen. Thomas Stafford
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
494 Million
(Quarterly Results - Jun 2025)
Net Profit:
-9 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 741 Million (Micro Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

156.80%

stock-summary
Debt Equity

0.67

stock-summary
Return on Equity

8.74%

stock-summary
Price to Book

0.88